The role of the neutral amino acid transporter B0AT1 (SLC6A19) in hartnup disorder and protein nutrition

Stefan Bröer*

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    90 Citations (Scopus)

    Abstract

    Hartnup disorder (OMIM 234500) is an autosomal recessive disorder, which was first described in 1956 as an aminoaciduria of neutral amino acids accompanied by a variety of symptoms, such as a photo-sensitive skin-rash and cerebellar ataxia. The disorder is caused by mutations in the neutral amino acid transporter B0AT1 (SLC6A19)1. To date 21 mutations have been identified in more than twenty families. SLC6A19 requires either collectrin or angiotensin-converting enzyme 2 for surface expression in the kidney and intestine, respectively. This ties SLC6A19 together with more complex functions such as blood-pressure control, glomerular structure, and exocytosis.

    Original languageEnglish
    Pages (from-to)591-599
    Number of pages9
    JournalIUBMB Life
    Volume61
    Issue number6
    DOIs
    Publication statusPublished - 2009

    Fingerprint

    Dive into the research topics of 'The role of the neutral amino acid transporter B0AT1 (SLC6A19) in hartnup disorder and protein nutrition'. Together they form a unique fingerprint.

    Cite this